Free Trial

Generali Asset Management SPA SGR Decreases Stock Holdings in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • Generali Asset Management SPA SGR decreased its holdings in Synopsys, Inc. by 11.7% in Q2, now owning 14,905 shares with a value of approximately $7.64 million.
  • Corporate insiders, including CFO Shelagh Glaser and CEO Sassine Ghazi, have sold significant shares, resulting in position decreases of 19.27% and 13.70% respectively.
  • Analysts have lowered their target prices for Synopsys, with Robert W. Baird adjusting its target from $670.00 to $535.00, reflecting a shift in sentiment toward the stock.
  • MarketBeat previews the top five stocks to own by November 1st.

Generali Asset Management SPA SGR cut its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 11.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,905 shares of the semiconductor company's stock after selling 1,973 shares during the quarter. Generali Asset Management SPA SGR's holdings in Synopsys were worth $7,641,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the business. Cornerstone Planning Group LLC increased its holdings in Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock worth $25,000 after buying an additional 44 shares during the last quarter. Saudi Central Bank purchased a new stake in shares of Synopsys during the 1st quarter worth approximately $26,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 53 shares during the last quarter. Independence Bank of Kentucky increased its stake in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 30 shares during the last quarter. Finally, WPG Advisers LLC purchased a new stake in shares of Synopsys during the 1st quarter worth approximately $34,000. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the business's stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the transaction, the chief financial officer owned 15,317 shares of the company's stock, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the transaction, the chief executive officer directly owned 71,615 shares of the company's stock, valued at approximately $42,181,951.15. This represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Corporate insiders own 0.62% of the company's stock.

Analyst Ratings Changes

A number of analysts have issued reports on SNPS shares. Robert W. Baird reissued a "neutral" rating and issued a $535.00 target price (down from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Baird R W lowered Synopsys from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 10th. Wall Street Zen lowered Synopsys from a "hold" rating to a "sell" rating in a report on Saturday, September 13th. Piper Sandler reduced their target price on shares of Synopsys from $660.00 to $630.00 and set an "overweight" rating for the company in a research note on Wednesday, September 10th. Finally, KeyCorp reduced their target price on shares of Synopsys from $660.00 to $590.00 and set an "overweight" rating for the company in a research note on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $569.67.

Check Out Our Latest Stock Analysis on Synopsys

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $435.90 on Thursday. The company has a 50 day moving average of $532.75 and a 200 day moving average of $510.07. The stock has a market cap of $80.97 billion, a P/E ratio of 34.22, a P/E/G ratio of 4.89 and a beta of 1.10. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing analysts' consensus estimates of $3.75 by ($1.45). The firm had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm's revenue for the quarter was up 14.0% on a year-over-year basis. During the same quarter last year, the firm earned $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.